Summary
Carpentier-Edwards Perimount valves have a proven track record of low reoperation rates in aortic valve replacement. The St. Jude Medical Trifecta is a newer valve that has shown comparable outcomes. Given midterm data for Trifecta is still sparse, we wanted to confirm the low early reoperation rates of Trifecta persist over time. The reoperation rates of Perimount and Trifecta were comparable, with Trifecta showing higher rates in patients younger than 60 years, and current smokers.